Viela Bio Reports Fourth Quarter and Full Year 2020 Operating and Financial Results

NEXT STORY
Turning Point Therapeutics Reports Fourth-Quarter and Full-Year Financial Results, Provides Operational Updates
PREV STORY
Adverum Announces Shortened Timelines and Clear Development Path for ADVM-022 Intravitreal Gene Therapy in Wet AMD, Reports Recent Business Progress and Fourth Quarter 2020 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Medical Devices Outsourcing Market to Expand at 11.6% CAGR till 2018 owing to Increasing Demand for Quality Healthcare Services: Transparency Market Research

Albany - NY, Oct. 20, 2015 (GLOBE NEWSWIRE) -- A new report has been ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: Finnish FIT Biotech and US Ichor to collaborate on new cost effective infectious disease treatment

FIT BIOTECH OY Company releaseApril 5th, 2016 at 9:00 am EET Finnish FIT Biotech ...

author_avatar
NASDAQ Market News

Genocea Announces Positive Interim Immunogenicity Data from GEN-009 Neoantigen Vaccine Phase 1/2a Clinical Trial

author_avatar
NASDAQ Market News